GUERRIERO, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 183.021
NA - Nord America 15.855
AS - Asia 2.112
SA - Sud America 51
OC - Oceania 25
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 201.102
Nazione #
IT - Italia 177.312
US - Stati Uniti d'America 15.769
UA - Ucraina 1.689
SE - Svezia 1.374
DE - Germania 1.338
CN - Cina 1.283
SG - Singapore 573
GB - Regno Unito 422
FI - Finlandia 407
RU - Federazione Russa 177
FR - Francia 125
CA - Canada 76
IN - India 73
VN - Vietnam 56
NL - Olanda 38
BR - Brasile 36
BE - Belgio 30
IR - Iran 25
ES - Italia 18
HK - Hong Kong 18
KR - Corea 17
EU - Europa 16
AT - Austria 13
AU - Australia 13
RO - Romania 13
TR - Turchia 13
NZ - Nuova Zelanda 12
IE - Irlanda 9
PH - Filippine 8
CO - Colombia 7
HU - Ungheria 6
BG - Bulgaria 5
EG - Egitto 5
ID - Indonesia 5
IL - Israele 5
JP - Giappone 5
LK - Sri Lanka 5
LT - Lituania 5
MX - Messico 5
PL - Polonia 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
MU - Mauritius 4
ZA - Sudafrica 4
AR - Argentina 3
BD - Bangladesh 3
GR - Grecia 3
HR - Croazia 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GE - Georgia 2
IQ - Iraq 2
IS - Islanda 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
EC - Ecuador 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 201.102
Città #
Cagliari 170.353
Uta 5.778
Fairfield 2.260
Woodbridge 1.567
Ashburn 1.152
Boardman 1.132
Houston 1.103
Chandler 1.095
Wilmington 927
Seattle 926
Ann Arbor 919
Jacksonville 902
Nyköping 862
Cambridge 781
Boston 272
Singapore 266
Dearborn 263
Nanjing 259
Santa Clara 179
Helsinki 158
Beijing 143
San Diego 137
Milan 132
Nanchang 91
Shanghai 79
Changsha 77
Shenyang 77
Guangzhou 74
Jiaxing 66
New York 65
Rome 65
Toronto 61
Verona 60
Hebei 59
London 52
Los Angeles 52
Dong Ket 50
Redwood City 47
Norwalk 46
Sassari 46
Tianjin 42
Orange 40
Mountain View 36
San Mateo 36
Falls Church 35
Pune 35
Ningbo 32
Washington 32
Jinan 30
Auburn Hills 27
Brussels 27
Zhengzhou 26
Augusta 19
Council Bluffs 19
Hefei 18
Nuremberg 18
Hong Kong 17
Chicago 16
Kunming 16
Redmond 16
Leawood 15
Saint Petersburg 15
Ardabil 14
Borås 14
Wuhan 14
Millbury 13
Monmouth Junction 13
Taizhou 13
Torino 11
Chiswick 10
Hangzhou 10
Mumbai 10
Quartu Sant'elena 10
Bologna 9
New Bedfont 9
Amsterdam 8
Frankfurt am Main 8
Munich 8
Seoul 8
Paris 7
Sydney 7
Walnut 7
Budapest 6
Catania 6
Naples 6
Rockville 6
Vienna 6
Villacidro 6
Yellow Springs 6
Yiwu 6
Barcelona 5
Colombo 5
Dalian 5
Dublin 5
Edinburgh 5
Fuzhou 5
Hamilton 5
Maniago 5
Phoenix 5
Piscataway 5
Totale 193.501
Nome #
Overview of elagolix for the treatment of endometriosis 3.449
Three-dimensional ultrasonography in the diagnosis of deep endometriosis 3.184
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis. 2.763
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis 2.627
Placental growth factor and preterm delivery 2.102
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.010
Deep Infiltrating Endometriosis: Comparison Between 2-Dimensional Ultrasonography (US), 3-Dimensional US, and Magnetic Resonance Imaging 1.999
Transvaginal ultrasound (TVS) versus Magnetic Resonance (MR) for diagnosing deep infiltrating endometriosis: a systematic review and meta-analysis 1.984
Learning curve for ultrasonographic diagnosis of deep infiltrating endometriosis using structured offline training program 1.952
OC15.07: Ultrasonographic “soft” markers for the detection of rectosigmoid endometriosis 1.915
OC04.04: Is the introduction of magnetic resonance in the diagnostic workout of adnexal masses just an increase of costs when IOTA Simple Rules are applied? 1.884
Does the clinical information play a role in the magnetic resonance diagnostic confidence analysis of ovarian and deep endometriosis? 1.879
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.874
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.844
Past, present and future ultrasonographic techniques for analyzing ovarian masses 1.815
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.673
Investigational drugs for the treatment of endometriosis, an update on recent developments 1.664
Diagnostic confidence analysis in the magnetic resonance imaging of ovarian and deep endometriosis: comparison with surgical results 1.623
ADDITIONAL VALUE OF CA-125 TO ULTRASOUND FOR PREDICTING SPECIFIC DIAGNOSIS OF BENIGN ADNEXAL CYSTS IN PREMENOPAUSAL 1.621
Tissue characterization using mean gray value analysis in deep infiltrating endometriosis 1.613
Endometriosis: the role of magnetic resonance imaging 1.479
Ultrasound features of rare primary malignant ovarian tumors 1.468
Diagnostic performance of transvaginal power Doppler ultrasound for predicting malignancy of adnexsal masses in in symptomatic and asymptomatic women 1.460
OC24: The role of magnetic resonance imaging and transvaginal ultrasonography in patients with an adnexal mass and chronic pelvic pain or infertility 1.447
Dietary composition of pregnant women in south sardinia 1.326
Influence of cryopreservation on perinatal outcome after blastocyst- vs cleavage-stage embryo transfer: systematic review and meta-analysis 1.323
Magnetic resonance imaging and transvaginal modified ulrasonography in the diagnosis of rectosigmoid endometriosis 1.271
Pattern of bone markers during pregnancy and their changes after delivery. 1.254
Ultrasound features of metastases in the ovary depending of the origin of the primary tumor 1.248
Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study 1.239
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.239
Malignancy risk of sonographically benign appearing purely solid adnexal masses in asymptomatic postmenopausal women 1.194
Counting ovarian antral follicles by ultrasound: a practical guide 1.184
Two-dimensional hysterosalpingo-contrast-sonography compared to three/four-dimensional hysterosalpingo-contrast-sonography for the assessment of tubal occlusion in women with infertility/subfertility: a systematic review with meta-analysis 1.176
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.169
The Reproducibility of Ultrasonographic Findings of Rectosigmoid Endometriosis Among Examiners With Different Level of Expertise 1.156
Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus? 1.145
Advances in Imaging for Assessing Pelvic Endometriosis 1.135
The treatment of polycystic ovary syndrome 1.131
External validation of IOTA simple descriptors and simple rules for classifying adnexal masses 1.120
Age-related differences in the sonographic characteristics of endometriomas 1.109
Reproducibility of the International Endometrial Analysis Group color score for assigning the amount of flow within the endometrium using stored 3-dimensional volumes 1.100
Training performance in diagnosis of congenital uterine anomalies with 3-dimensional sonography: A learning curve cumulative summation analysis 1.094
Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group 1.084
The distribution of stroma and antral follicles differs between insulin-resistance and hyperandrogenism-related polycystic ovarian syndrome 1.074
Long-term results for expectant management of ultrasonographically diagnosed benign ovarian teratomas 1.070
Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: A systematic review and meta-analysis 1.046
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 1.002
Extragenital endometrial stromal sarcoma arising in endometriosis 1.001
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 913
OC15.03: Diagnosing septate uterus using 3D ultrasound using three different classifications: an inter‐ and intraobserver agreement study 909
Usefulness of 3D power Doppler angiography technique to the third step in the differential diagnosis of adnexal masses. A prospective study 895
Non-enhanced Transvaginal Ultrasonography 892
Two-dimensional transvaginal sonography vs saline contrast sonohysterography for diagnosing endometrial polyps: systematic review and meta-analysis 875
Ovarian Tissue Characterization in Ultrasound: A Review 865
The ovarian endometrioma: clinical setting and ultrasound findings 850
The importance of transient myometrial contractions in the diagnosis of adenomyosis and congenital uterine anomalies 850
Differential Diagnosis of the most common benign ovarian cysts using transvaginal ultrasonography: Results of Sardinia-Navarra (Sa.Na.) group 848
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 840
Ultrasonography and atypical sites of endometriosis 830
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. 827
Prevalence of deep endometriosis in patients of a second level ultrasound laboratory and tissue US characterization of nodules using VOCAL 826
Transvaginal color Doppler in the detection of ovarian cancer in a large study population of postmenopausal women 823
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group 823
MDCT Angiography of the anterior spinal artery 819
Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors) 812
Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer 798
VP61.02: ROMA index versus ultrasound expert evaluation for detecting malignancy in adnexal masses classified as inconclusive by IOTA Simple Rules 798
Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome 792
Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus 774
Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study 762
Intensive training program for ultrasound diagnosis of adnexal masses: protocol and preliminary results. 748
Expectant management of adnexal masses in selected premenopausal women: a prospective observational study. 748
Three-dimensional sonography for diagnosis of rectovaginal septum endometriosis: interobserver agreement 747
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 744
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 736
VP63.04: Non‐expert interobserver agreement for sonographic diagnosis of adenomyosis 736
Imaging in gynecological disease (20): clinical and ultrasound characteristics of adnexal torsion 727
OC19.04: Soft markers as a first line ultrasonographic tool to raise suspicion of uterosacral involvement in women suspected of having deep endometriosis 709
IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation. 700
Sonohistology: the use simple findings to predct the histological diagnosis in more than 900 adnexal masses evaluated by single center 692
Transvaginal color Doppler in the detection of ovarian cancer in a large study population: Results of Sardinia-Navarra (Sa.Na.) group 691
VP61.01: MRI versus ultrasound expert evaluation for detecting malignancy in adnexal masses classified as inconclusive by IOTA Simple Rules 683
OC19.04: Diagnostic value of transvaginal ultrasonography for the prediction of parametrial endometriosis 681
Imaging for Endometriosis in Adolescents 679
Vessel morphology depicted by three-dimensional power Doppler ultrasound as a second stage test in difficult adnexal tumors: a prospective diagnostic accuracy study 664
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies 658
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa’ italiana di Ginecologia E Ostetricia) 658
Ovarian tumor characterization and classification using ultrasound-a new online paradigm. 656
Role of imaging in the management of endometriosis 637
Ultrasound in the Diagnosis of Deep Endometriosis 632
Differential diagnosis of endometriosis by ultrasound: A rising challenge 626
VP62.15: The absence of endometrioma doesn't mean absence of deep endometriosis: a new challenge 620
VP66.03: Transvaginal ultrasound colour Doppler in early diagnosis of ovarian cancer: a 20‐year experience 612
Diagnostic accuracy of transvaginal sonography for detecting parametrial involvement in women with deep endometriosis: systematic review and meta-analysis 605
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy 601
Assessing the reproducibility of the IOTA simple ultrasound rules for classifying adnexal masses as benign or malignant using stored 3D volumes 598
Imaging in gynecological disease (13): Clinical and ultrasound characteristics of endometrioid ovarian cancer 598
Ultrasound and clinical preoperative characteristics for discrimination between ovarian metastatic colorectal cancer and primary ovarian cancer: A case-control study 597
VP62.13: Ultrasonographic soft markers as a first‐line tool to raise suspicion of forniceal involvement in women suspected of having deep endometriosis 597
Totale 114.020
Categoria #
all - tutte 299.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.503 0 0 0 0 0 0 0 1.291 822 611 840 939
2020/202138.724 1.425 1.374 1.572 9.320 8.479 4.434 4.735 2.197 710 1.626 1.615 1.237
2021/202213.172 1.412 1.022 689 987 1.250 962 875 697 1.185 1.059 1.447 1.587
2022/202322.078 1.848 2.492 2.296 1.690 1.466 1.983 1.045 3.012 1.744 1.200 2.292 1.010
2023/202425.970 1.320 1.240 1.339 2.148 2.702 4.308 4.304 1.691 1.208 1.731 2.037 1.942
2024/202535.953 5.429 8.150 6.275 5.349 2.702 2.902 5.020 126 0 0 0 0
Totale 201.761